<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">

NEWSROOM Press Releases

    Year
    2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

    254 Results

    Biodesix Oral Presentation At SITC: Testing Methodology May Identify Primary Immunotherapy Resistance In Patients

    November 7, 2017

    Biodesix is making an oral presentation at SITC regarding a testing methodology that may identify primary immunotherapy resistance in patients

    Society for Advanced Bronchoscopy Meets May 20 to Address “Hot Topics in Advanced Bronchoscopy"

    May 15, 2018

    The Society for Advanced Bronchoscopy (SAB) will hold its second meeting: Hot Topics in Advanced Bronchoscopy.

    Society for Advanced Bronchoscopy Commits to Enhance Education and Practice Excellence as U.S. Demand for Bronchoscopy Procedures Increases

    May 29, 2018

    Bronchoscopy professionals in the United States need greater educational and practice-building support to ensure continued delivery of high-quality care for Americans

    New Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment Decisions

    April 30, 2018

    New data demonstrate that a blood-based proteomic test reliably assesses individual patient prognosis to inform treatment decisions.

    Biodesix’s Diagnostic Cortex™ Platform Used in Three Studies Presented at SITC

    November 15, 2016

    The study results indicate that the tests have the potential to offer clinically relevant information that could help physicians selecting immunotherapies for their patients make the best decision

    Blood-Based Diagnostic Assay Measures Immunotherapy Biomarker PD-L1

    February 27, 2017

    Biodesix released data at ASCO-SITC on a new assay that measures PD-L1 in the blood of cancer patients.

    Study Results from Biodesix’s Immunotherapy Test Will Be Presented by Dr. Jeffrey Weber

    March 20, 2017

    Dr. Jeffrey Weber will present study results of new Biodesix immunotherapy test at ITOC4

    Biodesix Announces Biomarker Research Collaboration with Checkmate Pharmaceuticals

    March 20, 2018

    Biodesix announced a biomarker research collaboration with Checkmate Pharmaceuticals, using Biodesix's proprietary discovery platform, the Diagnostic Cortex